Please assess the completion status of the following clinical trial:

Trial Title: Intra Uterine Device Insertion in Nulliparous Women

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Desires IUD placement~* 18 years old or older~* negative pregnancy test~* no prior pregnancies beyond 14 6/7 weeks~* no pelvic inflammatory disease (PID) in last 3 months~* no current cervicitis~* no contraindications to IUD insertion (see exclusion criteria below)~* willing to follow-up in 6-8 weeks for a standard IUD follow-up visit~* Determined by her clinician to be an appropriate candidate for an IUD.~Exclusion Criteria:~* Active cervical infection~* current pregnancy~* prior pregnancy beyond 15 weeks' gestation~* uterine anomaly~* fibroid uterus~* copper allergy/Wilson's disease (for Paragard)~* undiagnosed abnormal uterine bleeding~* cervical or uterine cancer~* allergy to misoprostol (study drug)

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- Experimental active comparator (Type: EXPERIMENTAL): Drug: Misoprostol~Experimental: 400 mcg taken sublingually 2 hours prior to IUD insertion
- Placebo comparator (Type: PLACEBO_COMPARATOR): Other: Placebo~Pill identical to study drug in appearance, taste, smell. Taken sublingually 2 hours prior to IUD insertion

Based on this trial design, predict the completion outcome and termination type (if applicable).